The Johns Hopkins BRAF Brain Tumor Center aims to help patients with brain tumors that originated in the brain (primary brain tumors) that have a BRAF gene mutation. Our multispecialty team includes experts across neurosurgery and the Johns Hopkins Kimmel Cancer Center who provide patient care and conduct research to improve outcomes for patients with these rare tumors.
What We Do
Evaluate and treat patients with BRAF-mutated primary brain tumors.
Partner with our basic science colleagues to discover mechanisms of resistance, clinically relevant targets and new pathway-specific drugs.
Neuro-oncologists
Radiation Oncologists
Advanced Practitioners
Christie Adams, PA-C
Jill Anderson, PA-C
Ashley Kang, PA-C
Carla Scott, PA-C
Glioblastoma and BRAF Gene Mutation | Courtney’s Story
After being diagnosed with a glioblastoma brain tumor in 2008, Courtney’s prognosis was not good. A referral to neuro-oncologist Karisa Schreck and neurosurgeon Jon Weingart changed the course of her illness. They identified the tumor as having a specific mutation in the BRAF gene, and they used a combination of surgery, conventional chemoradiation and targeted therapy to reduce its size and then keep the cancer in remission.